Prevention of immunoglobulin E production as a therapeutic target

被引：1

作者：

Woisetschläger, M ^{[1
]}

Stütz, AM ^{[1
]}

Ettmayer, P ^{[1
]}

机构：

[1] Novartis Forschungsinst, Dept Allerg Dis, A-1230 Vienna, Austria

来源：

DRUG NEWS & PERSPECTIVES | 2002年 / 15卷 / 02期

关键词：

D O I：

10.1358/dnp.2002.15.2.704649

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Immunoglobulin E (IgE) has been known for quite some years to be critically involved in the initiation of a number of allergic diseases. Its importance as therapeutic target was confirmed and strengthened by recent evidence that neutralizing monoclonal antibodies directed against IgE showed clinical efficacy in large clinical trials with patients suffering from asthma and allergic rhinitis. These data, for the first time, confirmed the predictions made from results obtained in numerous animal studies. This contribution discusses the importance of IgE as therapeutic target in allergic diseases with special emphasis on approaches aimed at inhibiting IgE synthesis by B-lymphocytes. (C) 2002 Prous Science. All rights reserved.

引用

页码：78 / 84

页数：7

共 50 条

[41] Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment
Gobert, Alain P.
Asim, Mohammad
Smith, Thaddeus M.
Williams, Kamery J.
Barry, Daniel P.
Allaman, Margaret M.
McNamara, Kara M.
Hawkins, Caroline V.
Delgado, Alberto G.
Zhao, Shilin
Piazuelo, M. Blanca
Washington, M. Kay
Coburn, Lori A.
Rathmacher, John A.
Wilson, Keith T.
ONCOGENE, 2023, 42 (20) : 1685 - 1691
[42] Interferon-γ is a therapeutic target molecule for prevention of postoperative adhesion formation
Kosaka, Hisashi
Yoshimoto, Tomohiro
Yoshimoto, Takayuki
Fujimoto, Jiro
Nakanishi, Kenji
NATURE MEDICINE, 2008, 14 (04) : 437 - 441
[43] Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention
Sih-han Wang
Shiaw-Yih Lin
Experimental Hematology & Oncology, 2 (1)
[44] Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention
Wang, Sih-han
Lin, Shiaw-Yih
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2013, 2
[45] PREVENTION OF END MT AND MYOFIBROBLAST PROLIFERATION AS A THERAPEUTIC TARGET FOR CARDIAC FIBROSIS
Okayama, Keita
Taniyama, Yoshiaki
Dosaka, Norio
Azuma, Junya
Sanada, Fumihiro
Kusunoki, Hiroshi
Iwabayashi, Masaaki
Rakugi, Hiromi
Morishita, Ryuichi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E290 - E290
[46] Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia
Rajji, Tarek K.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (01) : 21 - 28
[47] Interferon-γ is a therapeutic target molecule for prevention of postoperative adhesion formation
Hisashi Kosaka
Tomohiro Yoshimoto
Takayuki Yoshimoto
Jiro Fujimoto
Kenji Nakanishi
Nature Medicine, 2008, 14 : 437 - 441
[48] UNEXPECTED FINDINGS FROM TARGET ANALYSIS OF IMMUNOGLOBULIN-E AND ITS RECEPTOR
FEWTRELL, C
KEMPNER, E
POY, G
METZGER, H
BIOCHEMISTRY, 1981, 20 (23) : 6589 - 6594
[49] The immunoglobulin E allergen interaction: A target for therapy of type I allergic diseases
Valenta, R
Almo, S
Ball, T
Dolecek, C
Steinberger, P
Laffer, S
Eibensteiner, P
Flicker, S
Vrtala, S
Spitzauer, S
Valent, P
Denepoux, S
Kraft, D
Banchereau, J
Lebecque, S
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 116 (03) : 167 - 176
[50] Prostaglandin E2 synthase inhibition as a therapeutic target
Iyer, Jitesh P.
Srivastava, Punit K.
Dev, Rishabh
Dastidar, Sunanda G.
Ray, Abhijit
EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 849 - 865

← 1 2 3 4 5 →